Training future researchers in molecular biology
Molecular Biology Across Scales Training Program
The MBAS program at UC Berkeley is designed to help students learn how tiny molecules and cells work together to support life and health, and it's especially welcoming to those from underrepresented backgrounds.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10878676 on NIH RePORTER |
What this research studies
The Molecular Biology Across Scales (MBAS) program at UC Berkeley aims to train the next generation of researchers in understanding how molecules, cells, and tissues interact to promote life and improve human health. This multidisciplinary program offers broad-based training across various fields of molecular biology, allowing students to explore diverse research areas before specializing. The program will enroll 40 students over two years, focusing on inclusivity by targeting 30% of participants from historically excluded groups. Trainees will be required to publish a first-author paper and will typically complete their degree in about 5.5 years.
Who could benefit from this research
Good fit: Ideal candidates for this program are graduate students interested in pursuing a career in molecular biology and related fields.
Not a fit: Patients who are not pursuing graduate education in molecular biology or related disciplines may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could lead to significant advancements in molecular biology that enhance our understanding of health and disease.
How similar studies have performed: While this program is innovative in its multidisciplinary approach, similar training programs have successfully produced impactful research in the field of molecular biology.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Bilder, David — University of California Berkeley
- Study coordinator: Bilder, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.